Samwel Mikaye: Understanding D-Dimer in Clinical Practice
Samwel Mikaye, Medical Doctor at MSK, shared a post on LinkedIn:
”What is D-Dimer?
D-dimer is a protein fragment produced when a blood clot is broken down in the body. It is normally undetectable or very low in the blood, but levels rise when the body forms and breaks down clots.
It is used primarily as a lab test to help rule out clotting disorders.
Common Uses of D-Dimer Test
- Suspected Deep Vein Thrombosis (DVT) – Clots in deep veins, usually in legs.
- Pulmonary Embolism (PE) – Clots in the lungs.
- Disseminated Intravascular Coagulation (DIC) – Abnormal widespread clotting and bleeding.
- Sometimes used to monitor clot breakdown in known clotting conditions.
Interpretation
- Normal/Low D-dimer → Clotting disorder unlikely.
- High D-dimer → Suggests recent or ongoing clot formation and breakdown, but not specific. Many conditions can raise D-dimer:
- Infection
- Inflammation
- Recent surgery or trauma
- Liver disease
- Cancer
Important: A high D-dimer does not confirm a clot. Imaging (like Doppler ultrasound or CT scan) is usually needed to diagnose DVT or PE.
Advantages
- Quick blood test.
- Good for ruling out clots in low-risk patients.
Limitations
- Non-specific – many conditions can raise it.
- Not useful alone to diagnose a clot.
- Less reliable in elderly patients or those with chronic illnesses.
Think of D-dimer as a ‘smoke alarm’: a high level signals something may be wrong with clotting, but you need further tests to find the fire (actual clot).”
Other posts featuring Samwel Mikaye on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers